Measuring wine yeast autofluorescence by spectral cytometry: a breakthrough in fermentation monitoring
Yeast autofluorescence increases significantly as the cells age, reaching a maximum when the cells are dead. This phenomenon can bias analysis results, if not differentiated from other background signals.
Expertise, impartiality and ISO17025: Amarok Biotechnologies’ LEP at the service of medical devices
Ludovic Chaillet, engineer at LEP, and Alexandre Rivoallan, reference technician, share their expertise on the evaluation process and explain why manufacturers call on Amarok Biotechnologies to validate their products.
The administrative challenges of IVDR Regulation 2017/746
Explore the administrative constraints related to this new regulation and the organizational implications for the in vitro diagnostic medical device (IVD) industry.
Amarok Biotechnologies, a French performance evaluation laboratory, renews its ISO 17025:2017 accreditation with an extension to blood group immunohematology
Amarok Biotechnologies is delighted to announce the renewal of its ISO 17025:2017 accreditation for its Performance Evaluation Laboratory (LEP), with an extension to blood group immunohematology, a key area in in vitro diagnostics (IVD).Amarok Biotechnologies is accredited EN ISO/IEC 17025:2017 for the evaluation of the analytical performance of in vitro diagnostic medical devices (IVD MD) […]
Launch of the revolutionary Bretta test B method for immunomagnetic purification of Brettanomyces coupled with flow cytometric analysis
Discover the future of oenology with Bretta Test B: a revolutionary advance in the detection and purification of Brettanomyces in wine.
Adapting yeast vitality measurement to winemaking routines production routine
Winemaking is based on alcoholic fermentation which induces the transformation of grape sugar into ethanol, mainly under the action of Saccharomyces cerevisiae.
Quantification of wine spoilage yeasts, Brettanomyces, by immuno-magnetic separation and flow cytometry
The risk of contamination by Brettanomyces during the winemaking process is an economic threat for producers.
Evaluation of analytical performance of the sthemO DDi M assay on the sthemO 301 analyzer
D-dimers (DDi) arise from the degradation of fibrin by plasmin. Precise measurement of their levels is essential for managing the risk of venous thromboembolism in ambulatory patients or in monitoring disseminated intravascular coagulation.
Evaluation of the accuracy of sthemO routine test performance on the sthemO 301 analyzer
Accueil > Ressources > Posters > Evaluation of the accuracy of sthemO routine test performance on the sthemO 301 analyzer Download the white paper on Brettanomyces Find out about sthemO trial evaluations on Stago’s sthemO 301 analyzer: a revolution in precision and reliability for routine hemostasis tests, validated by Amarok Biotechnologies. Download The hemostasis test […]
Performance evaluation of the thrombophilia hemostasis test panel on the sthemO 301 analyzer
Thrombophilia is a predisposition — congenital or acquired — to form blood clots, which carries a risk of thrombosis.